INS and hyperinsulinemic hypoglycemia, familial, 4: Promoting insulin secretion and increasing insulin sensitivity is a relatively ideal treatment direction for insulin resistance/deficiency lipid metabolism abnormalities, which can effectively accelerate the utilization or storage of FAs to reduce lipid toxicity.